Publications by authors named "Michaela Barbier"

Claim this Profile
D
Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co-Design Approach With General Practitioners and Patients.
Kristie Rebecca Weir, Clémentine Tombez, Yvonne Mattmann, Sofia C Zambrano, Eliza Ferguson, Michaela Barbier

Basic Clin Pharmacol Toxicol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contributing to a value-based health care framework for lung cancer patients in Switzerland - A methodological approach to merge routinely collected hospital data.
Michaela Carla Barbier, Katya Galactionova, Mark Lambiris, Leonel Oliveira, Florian Rüter

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care.
Angela Edith Schulthess-Lisibach, Renata Vidonscky Lüthold, Clémentine Tombez, Kristie Rebecca Weir, Martina Zangger, Michaela Barbier

BMJ Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland.
Tämer El Saadany, Judith Lupatsch, Michael Mark, Michaela Barbier, Tarun Mehra

Swiss Med Wkly· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.
Michaela Carla Barbier, Alicia Fengler, Esther Pardo, Arjun Bhadhuri, Niklaus Meier

Pharmacoeconomics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment.
Dominik Menges, Henock G Yebyo, Sergio Sivec-Muniz, Sarah R Haile, Michaela C Barbier

Eur Urol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer.
Michaela C Barbier, Yuki Tomonaga, Dominik Menges, Henock G Yebyo, Sarah R Haile

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland.
Michaela Barbier, Nicholas Durno, Craig Bennison, Mathias Örtli, Christian Knapp

Eur J Health Econ· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs.
Armin Zgraggen, Sandro Tiziano Stoffel, Michaela Carla Barbier, Urs Albert Marbet

Z Gastroenterol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland.
Michaela Carla Barbier, Esther Pardo, Cédric Michael Panje, Oliver Gautschi, Judith Eva Lupatsch

Eur J Health Econ· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study.
Yves Allemann, Belen Fraile, Michel Lambert, Michaela Barbier, Philippe Ferber

J Clin Hypertens (Greenwich)· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma.
Laurence J Brookman, Lisa J Knowles, Michaela Barbier, Brigitte Elharrar, Rainard Fuhr

Curr Med Res Opin· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis